ProBlen DNA RNA Rejuvenation
- Manufacturer
- Liddell Laboratories, Inc.
- Effective date
- 2012-02-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:03:32
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: Arnica montana 6X, Avena sativa 3X, Damiana 3X, DNA 9X, Korean ginseng 3X, Oleum animale 6X, Pituitary bovinum 5C, 7C, 9C, RNA 9X, Thuja occidentalis 6X, Tribulus terrestris 3X.
OTC - PURPOSE SECTION
INDICATIONS: Temporarily supports symptoms of a run-down condition or advancing age. Symptoms may include: Low energy, poor muscular strength and stamina, pain and stiffness in muscles and joints, forgetfulness, inability to concentrate.
WARNINGS SECTION
WARNINGS: Not for use on children. If symptoms continue to recur, or if sleeplessness persists continuously for more than two weeks, consult a physician. Insomnia may be a symptom of a serious underlying medical illness.
As with all medicines, if you are pregnant or breast feeding, consult a health professional before using this product.
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
TAMPER EVIDENT: There is a seal around the neck of the bottle. Do not use if this seal is broken or missing.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: Adults: Hold the spray-top close to your open mouth and spray twice directly under your tongue, three times a day. Some people notice improvement within two or three weeks, others take longer.
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS: Organic alcohol 20% v/v, Purified water.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF THE REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away.
INDICATIONS & USAGE SECTION
INDICATIONS: Temporarily supports symptoms of a run-down condition or advancing age. Symptoms may include: Low energy, poor muscular strength and stamina, pain and stiffness in muscles and joints, forgetfulness, inability to concentrate.
OTC - QUESTIONS SECTION
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DNA RNA
HOMEOPATHIC ORGANOTHERAPY
1.0 FL OZ (30 ML)
proBLEN
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50845-0132-3 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c48b-f6ea-e053-dbdaa90aa703 | ProBLEN DNA RNA Rejuvenation |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50845-0132-1 | ProBlen DNA RNA Rejuvenation | 30 mL in 1 BOTTLE, SPRAY | SPRAY | 30 | 1 | |
| 50845-0132-2 | ProBlen DNA RNA Rejuvenation | 1 in 1 CARTON | SPRAY | 1 | 1 | |
| 50845-0132-3 | ProBlen DNA RNA Rejuvenation | 1 in 1 CARTON | SPRAY | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50845-0132 | PROBLEN DNA RNA REJUVENATION (ARNICA MONTANA, AVENA SATIVA, DAMIANA, DNA, KOREAN GINSENG, OLEUM ANIMALE, PITUITARY BOVINUM, RNA, THUJA OCCIDENTALIS, TRIBULUS TERRESTRIS,) SPRAY [LIDDELL LABORATORIES, INC.] | 1 | Legacy NDC, 3 package rows | 20120207_d613f415-dbcf-422a-8ebd-0dcca808d82a.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARNICA MONTANA | ACTIVE INGREDIENT | O80TY208ZW | 1 | |
| ASIAN GINSENG | ACTIVE INGREDIENT | CUQ3A77YXI | 1 | |
| AVENA SATIVA FLOWERING TOP | ACTIVE INGREDIENT | MA9CQJ3F7F | 1 | |
| BOS TAURUS PITUITARY GLAND | ACTIVE INGREDIENT | 7JM57I419K | 1 | |
| CERVUS ELAPHUS HORN OIL | ACTIVE INGREDIENT | 7A7G0PQI12 | 1 | |
| HERRING SPERM DNA | ACTIVE INGREDIENT | 51FI676N6F | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE INGREDIENT | J17GBZ5VGX | 1 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE INGREDIENT | 1NT28V9397 | 1 | |
| TRIBULUS TERRESTRIS ROOT | ACTIVE INGREDIENT | 6WY8ROM74K | 1 | |
| TURNERA DIFFUSA LEAFY TWIG | ACTIVE INGREDIENT | RQ2CFA7WWJ | 1 | |
| ARNICA MONTANA | ACTIVE MOIETY | O80TY208ZW | 1 | |
| ASIAN GINSENG | ACTIVE MOIETY | CUQ3A77YXI | 1 | |
| AVENA SATIVA FLOWERING TOP | ACTIVE MOIETY | MA9CQJ3F7F | 1 | |
| BOS TAURUS PITUITARY GLAND | ACTIVE MOIETY | 7JM57I419K | 1 | |
| CERVUS ELAPHUS HORN OIL | ACTIVE MOIETY | 7A7G0PQI12 | 1 | |
| HERRING SPERM DNA | ACTIVE MOIETY | 51FI676N6F | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE MOIETY | J17GBZ5VGX | 1 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE MOIETY | 1NT28V9397 | 1 | |
| TRIBULUS TERRESTRIS ROOT | ACTIVE MOIETY | 6WY8ROM74K | 1 | |
| TURNERA DIFFUSA LEAFY TWIG | ACTIVE MOIETY | RQ2CFA7WWJ | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- ProBlen DNA RNA Rejuvenation
- Arnica montana, Avena sativa, Damiana, DNA, Korean ginseng, Oleum animale, Pituitary bovinum, RNA, Thuja occidentalis, Tribulus terrestris,
- ARNICA MONTANA
- AVENA SATIVA FLOWERING TOP
- TURNERA DIFFUSA LEAFY TWIG
- ASIAN GINSENG
- THUJA OCCIDENTALIS LEAFY TWIG
- WATER
- ALCOHOL
- HERRING SPERM DNA
- SACCHAROMYCES CEREVISIAE RNA
- TRIBULUS TERRESTRIS ROOT
- CERVUS ELAPHUS HORN OIL
- BOS TAURUS PITUITARY GLAND
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50845-0132 | 50845-0132-1, 50845-0132-2, 50845-0132-3 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ARNICA MONTANA | O80TY208ZW | ACTIB |
| AVENA SATIVA FLOWERING TOP | MA9CQJ3F7F | ACTIB |
| TURNERA DIFFUSA LEAFY TWIG | RQ2CFA7WWJ | ACTIB |
| ASIAN GINSENG | CUQ3A77YXI | ACTIB |
| THUJA OCCIDENTALIS LEAFY TWIG | 1NT28V9397 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| HERRING SPERM DNA | 51FI676N6F | ACTIB |
| SACCHAROMYCES CEREVISIAE RNA | J17GBZ5VGX | ACTIB |
| TRIBULUS TERRESTRIS ROOT | 6WY8ROM74K | ACTIB |
| CERVUS ELAPHUS HORN OIL | 7A7G0PQI12 | ACTIB |
| BOS TAURUS PITUITARY GLAND | 7JM57I419K | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7f4ece5c-ea1f-4057-ae27-af1f05a50cb0 | d613f415-dbcf-422a-8ebd-0dcca808d82a | 2012-02-06 | Warnings | 7f4ece5c-ea1f-4057-ae27-af1f05a50cb0 d613f415-dbcf-422a-8ebd-0dcca808d82a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
